, Quelle est l'estimation du prix d'un gramme de cannabis ?

, Combien de joints faites-vous avec 20 euro ? _ _ _ _ Critères d'inclusion

, Le patient ne vient consulter que pour une consommation problématique de cannabis. Critères de non inclusion

, Les patients venant consulter pour une addiction à l'alcool, aux opiacés ou toutes autres substances.-Les patients présentant un trouble psychiatrique co-ocurrent ( trouble de l'axe I selon les critères du DSM IV) BIBLIOGRAPHIE

A. J. Budney and J. R. Hughes, The cannabis withdrawal syndrome, Curr Opin Psychiatry. mai, vol.19, issue.3, pp.233-241, 2006.

. , Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, pp.14-4863, 2014.

K. H. Levin, M. L. Copersino, S. J. Heishman, F. Liu, D. L. Kelly et al., Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers, Drug Alcohol Depend. 1 sept, vol.111, issue.1-2, pp.120-127, 2010.

T. Schwitzer, M. P. Robert, A. Giersch, K. Angioi-duprez, I. Ingster-moati et al., Transient Retinal Dysfunctions after Acute Cannabis Use, Eur Addict Res, vol.22, issue.6, pp.287-91, 2016.

(. Inserm and . Dir, Cannabis: Quels effets sur le comportement et la santé, Rapport. Paris : Les éditions Inserm, pp.215-232, 2001.

(. Inserm and . Dir, Cannabis: Quels effets sur le comportement et la santé, Rapport. Paris : Les éditions Inserm, 2001.

D. Souza, D. C. Sewell, R. A. Ranganathan, and M. , Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci, vol.259, pp.413-444, 2009.

P. D. Morrison, V. Zois, D. A. Mckeown, T. D. Lee, D. W. Holt et al., The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning, Psychol Med, vol.39, issue.10, pp.1607-1623, 2009.

M. Haney, S. D. Comer, A. S. Ward, R. W. Foltin, and M. W. Fischman, Factors influencing marijuana self-administration by humans, Behav Pharmacol. juin, vol.8, issue.2-3, pp.101-113, 1997.

. Inserm, Conduites addictives chez les adolescents : Usages, prévention et accompagnement. Les éditions Inserm, 2014.

S. Legleye, D. Piontek, and L. Kraus, Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents, Drug Alcohol Depend. 15 janv, vol.113, issue.2-3, pp.229-264, 2011.

R. D. Crean, N. A. Crane, and B. J. Mason, An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions, J Addict Med. mars, vol.5, issue.1, pp.1-8, 2011.

C. David and M. Robin, Marijuana and Madness, 2004.

A. D. Schweinsburg, S. A. Brown, and S. F. Tapert, The influence of marijuana use on neurocognitive functioning in adolescents, Curr Drug Abuse Rev. janv, vol.1, issue.1, pp.99-111, 2008.

N. A. Crane, R. M. Schuster, P. Fusar-poli, and R. Gonzalez, Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences, Neuropsychol Rev. juin, vol.23, issue.2, pp.117-154, 2013.
DOI : 10.1007/s11065-012-9222-1

URL : http://europepmc.org/articles/pmc3593817?pdf=render

A. M. Schreiner and M. E. Dunn, Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis, Exp Clin Psychopharmacol, vol.20, issue.5, pp.420-429, 2012.

A. Dervaux, X. Laqueille, M. Bourdel, L. Borgne, M. Olie et al., Cannabis et schizophrénie : données cliniques et socio-démographiques, Encéphale, vol.29, issue.1, pp.11-18, 2003.

T. Moore, S. Zammit, A. Lingford-hughes, T. Barnes, P. B. Jones et al., Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, Lancet Lond Engl. 28 juill, vol.370, issue.9584, pp.319-347, 2007.
DOI : 10.1016/s0140-6736(07)61162-3

URL : http://orca.cf.ac.uk/619/1/Appendix%201%20%28search%20strategy%29%20Cannabis%20use%20and%20risk%20of%20developing%20psychotic%20or%20affective%20mental%20health%20outcomes%20a%20systematic%20review.pdf

A. Dervaux and X. Laqueille,

, Presse Med. déc, vol.41, issue.12, pp.1233-1273, 2012.

Y. Morvan, J. Rouvier, J. Olié, H. Lôo, and M. Krebs, Student's use of illicit drugs: a survey in a preventive health service

, L'Encephale. déc, vol.35, issue.6, pp.202-208, 2009.

C. Henquet, R. Murray, D. Linszen, and J. Van-os, The environment and schizophrenia: the role of cannabis use, Schizophr Bull. juill, vol.31, issue.3, pp.608-620, 2005.

L. Arseneault, M. Cannon, R. Poulton, R. Murray, A. Caspi et al., Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study, BMJ, vol.325, issue.7374, pp.1212-1215, 2002.

S. Zammit, P. Allebeck, S. Andreasson, I. Lundberg, and G. Lewis, Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study, BMJ, vol.325, issue.7374, p.1199, 2002.

J. Van-os, M. Bak, M. Hanssen, R. V. Bijl, R. De-graaf et al., Cannabis use and psychosis: a longitudinal population-based study, Am J Epidemiol. 15 août, vol.156, issue.4, pp.319-346, 2002.

M. Large, S. Sharma, M. T. Compton, T. Slade, and O. Nielssen, Cannabis use and earlier onset of psychosis: a systematic meta-analysis, Arch Gen Psychiatry. juin, vol.68, issue.6, pp.555-61, 2011.

A. Dervaux, M. Krebs, and X. Laqueille, Is cannabis responsible for early onset psychotic illnesses? Neuropsychiatry, 2011.

R. Vandrey, A. J. Budney, J. L. Kamon, and C. Stanger, Cannabis withdrawal in adolescent treatment seekers, Drug Alcohol Depend. 9 mai, vol.78, issue.2, pp.205-215, 2005.

A. J. Budney and J. R. Hughes, The cannabis withdrawal syndrome, Curr Opin Psychiatry. mai, vol.19, issue.3, pp.233-241, 2006.

M. A. Dawes, A. Liguori, and D. M. Dougherty, Cannabis withdrawal among adolescent cannabis users in an outpatient research setting, Am J Addict. déc, vol.15, issue.6, pp.485-491, 2006.

M. C. Greene and J. F. Kelly, The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation, J Addict Med, vol.8, issue.5, pp.359-67, 2014.

E. S. Herrmann, E. M. Weerts, and R. Vandrey, Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users, Exp Clin Psychopharmacol. déc, vol.23, issue.6, pp.415-436, 2015.

M. P. Castelli, P. Fadda, A. Casu, M. S. Spano, A. Casti et al., Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones, Curr Pharm Des, vol.20, issue.13, pp.2100-2113, 2014.

R. M. Craft, J. A. Marusich, and J. L. Wiley, Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?, Life Sci. 19 mars, vol.92, issue.8-9, pp.476-81, 2013.

U. Bonnet, T. Borda, N. Scherbaum, and M. Specka, Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum, Drug Alcohol Depend, vol.155, pp.302-308, 2015.

V. Laprevote, N. Gambier, J. Cridlig, B. Savenkoff, J. Scala-bertola et al., Early withdrawal effects in a heavy cannabis smoker during hemodialysis, Biol Psychiatry. 1 mars, vol.77, issue.5, pp.25-26, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01451677

P. Gates, L. Albertella, and J. Copeland, Cannabis withdrawal and sleep: A systematic review of human studies, Subst Abuse, vol.37, issue.1, pp.255-69, 2016.

D. J. Allsop, M. M. Norberg, J. Copeland, S. Fu, and A. J. Budney, The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress, Drug Alcohol Depend. 1 déc, vol.119, issue.1-2, pp.123-132, 2011.

L. Ministère-de and . Santé, de la jeunesse et des sports, Direction générale de la santé D, HOUSSIN D. Circulaire DGS/MC2 n°2008-79 du 28 février 2008 relative à la mise en place des centres de soins, d'accompagnement et de prévention en addictologie et à la mise en place des schémas régionaux médico-sociaux d'addictologie, 2008.

W. , C. E. , and T. Jj, Direction générale de la santé D, Direction de l'hospitalisation et de l'organisation des soins D, Direction générale de l'action sociale D, DAB

D. Circulaire and . Dgas, septembre 2004 relative à la mise en place de consultations destinées aux jeunes consommateurs de cannabis et autres substances psychoactives et leur famille, 2004.

J. Copeland, W. Swift, R. Roffman, and R. Stephens, A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder, J Subst Abuse Treat. sept, vol.21, issue.2, pp.65-66, 2001.

A. L. Mcrae, A. J. Budney, and K. T. Brady, Treatment of marijuana dependence: a review of the literature, J Subst Abuse Treat. juin, vol.24, issue.4, pp.369-76, 2003.

H. B. Waldron and C. W. Turner, Evidence-based psychosocial treatments for adolescent substance abuse, J Clin Child Adolesc Psychol Off J Soc Clin Child Adolesc Psychol Am Psychol Assoc Div 53. janv, vol.37, issue.1, pp.238-61, 2008.

P. J. Gates, P. Sabioni, J. Copeland, L. Foll, B. Gowing et al., Psychosocial interventions for cannabis use disorder, Cochrane Database Syst Rev. 5 mai, issue.5, p.5336, 2016.

S. T. Higgins, S. M. Alessi, and R. L. Dantona, Voucher-based incentives. A substance abuse treatment innovation, Addict Behav. déc, vol.27, issue.6, pp.887-910, 2002.

C. Bonnaire, N. Bastard, J. Couteron, A. Har, and O. Phan, Multidimensional family therapy: which influences

L. 'encephale, , vol.40, pp.408-423, 2014.

M. Haney, C. L. Hart, S. K. Vosburg, J. Nasser, A. Bennett et al., Marijuana withdrawal in humans: effects of oral THC or divalproex, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. janv, vol.29, issue.1, pp.158-70, 2004.

A. J. Budney, R. Roffman, R. S. Stephens, and D. Walker, Marijuana dependence and its treatment, Addict Sci Clin Pract. déc, vol.4, issue.1, pp.4-16, 2007.

V. Laprevote, R. Schwan, T. Schwitzer, B. Rolland, and J. Thome, Is There a Place for OffLabel Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety, Curr Pharm Des, vol.21, issue.23, pp.3298-305, 2015.

D. A. Gorelick, Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review, Curr Pharm Des. 22 août, 2016.